Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Critical Therapeutics, Inc. Files for Initial Public Offering.


Business Editors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 19, 2004

Critical Therapeutics, Inc. announced today that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 the proposed initial public offering of its common stock. All of the shares being offered are to be sold by the company. The underwriters for this offering will be SG Cowen Securities Corporation, acting as sole book-running manager, and CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities.  Corp., Piper Jaffray Piper Jaffray & Co. (NYSE: PJC), often shortened to just Piper Jaffray or PiperJaffray, is a U.S. middle-market investment banking firm based in Minneapolis, Minnesota and is a focused on delivering financial advice, investment products and transaction execution  & Co. and Leerink Swann & Company, acting as co-managers. The number of shares to be offered and the price range for the offering have not yet been determined.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The offering may be made only be means of a prospectus, a copy of which may be obtained, when available, from SG Cowen Securities Corporation at 1221 Avenue of the Americas, 6th Floor, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10020 or through ADP (1) (Automatic Data Processing) Synonymous with data processing (DP), electronic data processing (EDP) and information processing.

(2) (Automatic Data Processing, Inc., Roseland, NJ, www.adp.
 by fax at (631) 254-7268.

About Critical Therapeutics

Critical Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products designed to regulate the body's inflammatory response associated with asthma and critical care diseases. The company is developing a sales and marketing infrastructure in connection with its in-licensed asthma product, zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic.
Zileuton (Zyflo) 
. Critical Therapeutics is also developing treatments directed toward the severe inflammatory response associated with acute diseases and conditions that lead to admission to the emergency room or intensive care unit, and acute exacerbations of chronic diseases that frequently lead to hospitalization hospitalization /hos·pi·tal·iza·tion/ (hos?pi-t'l-i-za´shun)
1. the placing of a patient in a hospital for treatment.

2. the term of confinement in a hospital.
.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Mar 19, 2004
Words:339
Previous Article:Newsday, a Tribune Group Company, Licenses AP/Stockgroup's Financial Content Solution.
Next Article:Pep Boys Prices Common Stock Offering.
Topics:



Related Articles
Over-allotment option exercised in Sequana Therapeutics Inc. initial public offering.
Connective Therapeutics Inc. files for initial public offering of common stock.
Neurocrine Biosciences Inc. Commences Initial Public Offering Of Common Stock.
Cell Therapeutics announces proposed public offering of 3 million common shares.
Critical Therapeutics, Inc. Announces Pricing of Initial Public Offering.
Critical Therapeutics to Initiate Phase I Study of Anti-Inflammatory Compound, CTI-01; Safety Trial to be Conducted in the U.S. in Approximately 60...
Critical Therapeutics Licenses Exclusive Patent Rights to Novel Family of Compounds from University of Florida.
Critical Therapeutics, Inc. Reports Financial Results for the Quarter and Nine Months Ended September 30, 2004.
Critical Therapeutics Reports Second Quarter 2005 Financial Results.
Critical Therapeutics Reports Third Quarter 2005 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles